$34.3bn
$X.Xbn
130k
468
$X.Xbn
The Dialysis Centers industry has performed well because it is crucial for patients with chronic kidney disease, making demand for services inelastic. The only substitute available for dialysis treatment is a kidney transplant, which typically entails many years of waiting and uncertainty. Even throughout the COVID-19 pandemic, when nonessential healthcare services were temporarily prohibited in many places, demand for dialysis continued to grow. Revenue has increased at a CAGR of 1.4% to an estimated $34.0 billion over the five years to 2023, including 3.9% growth in 2023 alone.
Industry revenue has grown at a CAGR of 1.4 % over the past five years, to reach an estimated $34.3bn in 2024.
Market size is projected to grow over the next five years.
Company | Market Share (%)
2023 | Revenue ($m)
2023 | Profit ($m)
2023 | Profit Margin (%)
2023 |
---|---|---|---|---|
Fresenius Medical Care Ag & Co. Kgaa | 13,386.7 | 1,869.8 | 14.0 | |
DaVita HealthCare Partners Inc. | 10,763.0 | 2,099.9 | 19.5 |
To view the market share and analysis for all 2 top companies in this industry, view purchase options.
Dialysis Centers in the US
Industry revenue is measured across several distinct product and services lines, including Outpatient hemodialysis, Peritoneal dialysis and Home-based hemodialysis. Outpatient hemodialysis is the largest segment of the Dialysis Centers in the US.
Outpatient hemodialysis is the most common form of dialysis
The Dialysis Centers industry includes medical facilities that provide inpatient and outpatient kidney or renal dialysis services.
Purchase this report to view all 2 major companies in this industry.
NAICS 62149 - Dialysis Centers in the US
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
The essential nature of dialysis and an ageing population have underscored demand. The only alternative to dialysis is a kidney transplant, which has long wait times and can ...
Learn about an industry's products and services, markets and trends in international trade.
Outpatient hemodialysis is the most common form of dialysis. Patients prefer to be treated in the presence of trained physicians.
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Location is tied to the distribution of the population. Regions with a higher number of Americans require more dialysis centers.
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Care quality is the hallmark of kidney dialysis centers. Nationwide operators are known for their high-quality service and positive clinical outcomes.
Learn about the performance of the top companies in the industry.
The dialysis industry is dominated by just two companies, Fresenius and DaVita. The two companies account for most of the available market.
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Certification from public healthcare programs is tantamount for success. Government is a substantial payer for dialysis under the End-Stage Renal Disease (ESRD) Program.
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Profitability across dialysis centers is high. However, as many patients rely on Medicare for service payments and reimbursement rates have declined, margins have been pressu...
Including values and annual change:
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Unlock comprehensive answers and precise data upon purchase. View purchase options.
The market size of the Dialysis Centers in the US industry in United States is $34.3bn in 2024.
There are 468 businesses in the Dialysis Centers in the US industry in United States, which has grown at a CAGR of 0.6 % between 2019 and 2024.
The market size of the Dialysis Centers in the US industry in United States has been growing at a CAGR of 1.4 % between 2019 and 2024.
Over the next five years, the Dialysis Centers in the US industry in United States is expected to grow.
The biggest companies operating in the Dialysis Centers market in United States are Fresenius Medical Care Ag & Co. Kgaa and DaVita HealthCare Partners Inc.
Outpatient hemodialysis and Hospital inpatient hemodialysis are part of the Dialysis Centers in the US industry.
The company holding the most market share in United States is Fresenius Medical Care Ag & Co. Kgaa.
The level of competition is moderate and steady in the Dialysis Centers in the US industry in United States.